Archives

by in
Entry Author Date Location
To Take On New York, Accelerator Makes Big Changes 08/14/14 New York
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
Accelerator Bags $51M, Makes Long-Awaited Move to NYC 07/29/14 New York
Agios’s Blood Cancer Drug Shines in First Clinical Test 04/06/14 Boston
10 Takeaways From New York’s Life Science Disruptors 03/10/14 New York
Robertson Gives Rockefeller $25M For Drug Discovery 01/23/14 New York
MD Anderson Expands “Moon Shots” Immunotherapy Partnership to J&J 01/21/14 Texas
Juno Therapeutics Adds Jeff Bezos, Venrock to $145M Venture Deal 01/13/14 Seattle
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
Houston’s MD Anderson Partners With Pfizer on Cancer Immunotherapies 01/08/14 Texas
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More 10/04/13 Boston
Tom Maniatis’ Dream of a NY Genome Center Becomes a Big Apple Reality 09/19/13 New York
Why Good Drugs Sometimes Fail: The Bexxar Story 08/26/13 National
East Coast Biotech Roundup: Moderna, bluebird, Blueprint 03/22/13 Boston
Memorial Sloan-Kettering and Eureka Go After ‘Undruggable’ Targets 03/21/13 New York
Has The Pendulum Swung Too Far in Favor of Rare Diseases? 03/14/13 Seattle
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
What’s in a Name? A Lot, When It Comes to ‘Precision Medicine’ 02/04/13 National
East Coast Life Sciences Roundup: Aveo, Mayo Clinic, GI Dynamics, More 01/18/13 Boston
Can NYC Create an Infrastructure for Medical Device Startups? 01/17/13 New York
GNS to Use Big Data to Fight Multiple Myeloma 11/08/12 Boston
Can New York Take on Boston, California as a Biotech Hub? 10/11/12 New York
Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut 08/01/12 New York
Pet Dogs Help Biotech Startups Find New Weapons to Fight Cancer 07/25/12 San Diego
Bristol-Myers Wrangles Top Academics to Study Immunity in Cancer 06/07/12 New York
Medivation Emerges With New Prostate Cancer Drug 05/31/12 San Francisco
Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 05/23/12 Seattle
San Diego’s Aragon Raises $42 Million, Targets Hormone-Driven Cancers 03/06/12 San Diego
Xconomists of the Week: Tom Maniatis and Marc Tessier-Lavigne Lead the Charge on the New York Genome Center 11/03/11 New York
Page 1 of 2 next page »